Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsGlenmarkpharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Dabur, Glenmark Pharma, Adani Ports, DLF: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Dabur India, Glenmark Pharma, Adani Ports and DLF.

    • Here are SP Tulsian's top trading ideas

      In an interview to CNBC-TV18's Anuj Singhal and Sonia Shenoy, SP Tulsian of sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.

    • No harm in subscribing to IT scrips despite gloom: SP Tulsian

      In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks and told why he is bullish on pharma stocks for the month of July.

    • Here are a few stocks to watch on July 7

      CNBC-TV18's research team gives a list of top 10 stocks for the day. Stocks expected to gain are Glenmark, REC, PNB, Claris, Equitas Holdings, J Kumar Infra, Satin Credit Care while stocks expected to be under pressure are Bharat Forge, Sobha, Canara Bank, IDBI Bank, JBF Ind,HCL Infosystems and GM Breweries.

    • Analysts say Glenmark's FCCB, Zetia, licensing deal key in FY17

      Macquarie that has outperform rating with a target price of Rs 1,140 on the stock, says GBR 1302 data in 2HFY17 will help validate BEAT platform and pave the way for a potential out-licensing deal in next 12 to 18 months.

    • M&M, pharma stocks, Mahanagar Gas: See SP Tulsian's top picks

      In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks for the day and talked about the listing of Mahanagar Gas on the Indian bourse.

    • Why pharma stocks can rally in July: SP Tulsian

      In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks and told why he has a positive stance on all pharma stocks for this coming month.

    • Brexit impact limited on pharma, US biz to offset risk: Analysts

      Brokerage houses do not see any major impact of Brexit on pharma companies' earnings. In fact they have not changed their views post Friday's event, saying companies may get impacted only by currency volatility globally. According to them, any EU impact will offset by US large exposure to the US.

    • SP Tulsian says pharma is theme for July series, go long in them

      I won‘t be surprised to see pharma as the story for July series and won‘t be surprised in seeing a big upsurge in all big pharma, said SP Tulsian.

    • Go long in Lupin, Glenmark, Strides Shasun: SP Tulsian

      SP Tulsian of sptulsian.com recommends going long in Lupin, Glenmark Pharma, Aurobindo Pharma and Strides Shasun.

    • Super Six: Top chart picks for June 21

      Mitesh Panchal of Affluence Shares & Stocks is of the view that one may buy Glenmark Pharma with a target of Rs 800.

    • Sell United Breweries, prefer Glenmark: Gaurang Shah

      Gaurang Shah of Geojit BNP Paribas suggests exiting United Breweries.

    • Sell Glenmark Pharma, Amara Raja, Bata India: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Glenmark Pharma, Amara Raja Batteries and Bata India.

    • Buy Tata Global, Mcleod Russel; short Strides Shasun: RK Global

      Rakesh Bansal, Vice President at R K Global is of the view that one can buy Tata Global Beverage and Mcleod Russel and short Strides Shasun and Glenmark Pharma.

    • Sell Glenmark Pharma, may slip to Rs 720: CA Rudramurthy BV

      CA Rudramurthy BV of Vachana Investments is of the view that one can sell Glenmark Pharma as the stock may test Rs 720.

    • Buy ITC, sell Bharat Petroleum Corporation: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy ITC and sell Bharat Petroleum Corporation.

    • Buy KPIT Tech, CONCOR, M&M Financial: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may buy Mahindra & Mahindra Financial Services and KPIT Technologies.

    • Divis Lab, Glenmark look weak; buy Bharti Airtel: Rajat Bose

      According to Rajat Bose of rajatkbose.com, Divis Laboratories and Glenmark Pharma are looking pretty weak.

    • Sell Glenmark Pharma; buy Karnataka Bank, PTC India: Gujral

      Ashwani Gujral of ashwanigujral.com advises selling Glenmark Pharma and suggests buying Karnataka Bank and PTC India.

    • Buy Dabur, Kotak Mahindra Bank; sell Glenmark: Sandeep Wagle

      Sandeep Wagle of powermywealth.com is of the view that one may buy Dabur India and Kotak Mahindra Bank.

    • Super Six stocks you can bet on June 6

      Digesh Shah of Veracity Fin is of the view that one may buy Tata Power Company with a target of Rs 76.

    • Bull's Eye: Buy Biocon, DB Realty, Rel Infra, Federal Bk, HPCL

      CA Rudramurthy is of the view that one may buy Balrampur Chini Mills with a target of Rs 119.

    • Buy Raymond, Radico Khaitan; short Glenmark: Amit Harchekar

      Amit Harchekar of A Plus Analytics recommends buying Raymond and Radico Khaitan and advises shorting Glenmark Pharma.

    • Buy Sun Pharma at around Rs 750: Mehraboon Irani

      Mehraboon Irani of Nirmal Bang Securities is of the view that one can buy Sun Pharma at around Rs 750.

    • Top stocks to keep your eye on June 1

      Here are a few stocks picked up by CNBC-TV18's analysts to keep on your radar for trade today. We have IDBI, Granules, BPCL, HPCL, IOC, Axis Bank, Coal India, Tata Power, NTPC, Glenmark Pharma, Britannia and Vakrangee.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347